Related Experiment Video
Updated: Jun 9, 2026
08:04
A Semiautomated ChIP-Seq Procedure for Large-scale Epigenetic Studies
Published on: August 13, 2020
Global Egr1-miRNAs binding analysis in PMA-induced K562 cells using ChIP-Seq
Wei Wang1, Dequang Zhou, Xiaolong Shi
1State Key Laboratory of Bioelectronics, School of Biological Sciences and Medical Engineering, Southeast University, Nanjing 210096, China.
Journal of Biomedicine & Biotechnology
|September 3, 2010
Summary
Researchers identified transcription factor Egr1 binding sites on microRNA genes in K562 cells. This study maps Egr1
Area of Science:
- Molecular Biology
- Genomics
- Epigenetics
Background:
- MicroRNAs (miRNAs) are crucial regulators of gene expression and cell fate.
- Identifying transcription factor binding sites on miRNA genes is essential for understanding gene regulation.
- Global mapping of transcription factor-miRNA gene interactions remains largely unexplored.
Purpose of the Study:
- To globally identify microRNA (miRNA) genes directly targeted by the transcription factor Egr1.
- To investigate the role of Egr1 in regulating miRNA expression in human erythroleukemia K562 cells.
Main Methods:
- Chromatin immunoprecipitation sequencing (ChIP-Seq) was employed to detect Egr1 binding sites across the genome.
- Quantitative ChIP-PCR assays were performed to validate specific Egr1-miRNA gene interactions.
Main Results:
- Egr1 binding sites were identified near the promoters of 124 distinct miRNA genes.
- Egr1 was found to bind to 63 additional pre-miRNA sequences.
- ChIP-PCR confirmed Egr1 binding to 12 selected miRNA genes, validating the ChIP-Seq findings.
Conclusions:
- This study presents the first global binding profile of Egr1 on its targeting miRNA genes in PMA-treated K562 cells.
- The findings provide insights into the regulatory network controlled by Egr1 in miRNA biology.
- This work facilitates a deeper understanding of pathways governing miRNA regulation in erythroleukemia.
